Cost-utility analysis of socazolimab combined with first-line chemotherapy for extensive-stage small cell lung cancer

CAO Lijuan, LIU Lulu, QIN Fang, LI Lingsong, XIE Ruijie, SHI Zhanying, LIU Daihua, LIU Chengyu

Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (3) : 315-320.

PDF(968 KB)
PDF(968 KB)
Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (3) : 315-320. DOI: 10.13286/j.1001-5213.2026.03.11
Drug and Clinical Practice

Cost-utility analysis of socazolimab combined with first-line chemotherapy for extensive-stage small cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 46(3): 315-320 https://doi.org/10.13286/j.1001-5213.2026.03.11

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(968 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉